Literature DB >> 973961

The influence of smoking on the intersubject variation in pentazocine elimination.

D P Vaughan, A H Beckett, D S Robbie.   

Abstract

The cumulative urinary excretion over 24 h of pentazocine, under conditions of acidic urinary pH, has been measured in smokers and non-smokers using both male and female subjects (seventy subjects in total). A restricted urban population was studied. An overall three-fold inter-subject variation in elimination was observed. The cumulative urinary excretion of pentazocine was normally distributed in both smokers and non-smokers. Smokers metabolize 40% more pentazocine than non-smokers. It is concluded that induction is principally responsible for the observed subject variability.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 973961      PMCID: PMC1428880          DOI: 10.1111/j.1365-2125.1976.tb00604.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  8 in total

1.  Atmospheric pollution and pentazocine metabolism.

Authors:  M Keeri-Szanto; J R Pomeroy
Journal:  Lancet       Date:  1971-05-08       Impact factor: 79.321

2.  Effect of cigarette smoking on phenacetin metabolism.

Authors:  E J Pantuck; K C Hsiao; A Maggio; K Nakamura; R Kuntzman; A H Conney
Journal:  Clin Pharmacol Ther       Date:  1974-01       Impact factor: 6.875

3.  Metabolism in vitro and in vivo of pentazocine.

Authors:  K A Pittman; D Rosi; R Cherniak; A J Merola; W D Conway
Journal:  Biochem Pharmacol       Date:  1969-07       Impact factor: 5.858

4.  Pharmacokinetic studies on pentazocine.

Authors:  M Mitchard
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1971

5.  Relationship of pentazocine plasma levels to pharmacological activity in man.

Authors:  B A Berkowitz; J H Asling; S M Shnider; E L Way
Journal:  Clin Pharmacol Ther       Date:  1969 May-Jun       Impact factor: 6.875

6.  The absorption and excretion of pentazocine after administration by different routes.

Authors:  R A Burt; A H Beckett
Journal:  Br J Anaesth       Date:  1971-05       Impact factor: 9.166

7.  Enzyme induction in man caused by smoking.

Authors:  A H Beckett; E J Triggs
Journal:  Nature       Date:  1967-11-11       Impact factor: 49.962

8.  An analysis of the inter-subject variation in the metabolism of pentazocine.

Authors:  D P Vaughan; A H Beckett
Journal:  J Pharm Pharmacol       Date:  1974-10       Impact factor: 3.765

  8 in total
  10 in total

Review 1.  Research review. Interactions between environmental chemicals and drug biotransformation in man.

Authors:  A P Alvares
Journal:  Clin Pharmacokinet       Date:  1978 Nov-Dec       Impact factor: 6.447

Review 2.  Pharmacokinetics of opioids in liver disease.

Authors:  I Tegeder; J Lötsch; G Geisslinger
Journal:  Clin Pharmacokinet       Date:  1999-07       Impact factor: 6.447

Review 3.  Role of tobacco smoking in pharmacokinetics.

Authors:  W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1978-02

4.  Clinical implications of Surgeon General's Report on Smoking and Health.

Authors: 
Journal:  J Natl Med Assoc       Date:  1979-07       Impact factor: 1.798

5.  The relationships between clinical response, psychophysiological variables and plasma levels of amitriptyline and diazepam in neurotic outpatients.

Authors:  E C Johnstone; R C Bourne; T J Crow; C D Frith; S Gamble; R Lofthouse; F Owen; D G Owens; J Robinson; M Stevens
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

Review 6.  Recent developments in the study of the effects of cigarette smoking on clinical pharmacokinetics and clinical pharmacodynamics.

Authors:  L G Miller
Journal:  Clin Pharmacokinet       Date:  1989-08       Impact factor: 6.447

Review 7.  Drug interactions with tobacco smoking. An update.

Authors:  S Zevin; N L Benowitz
Journal:  Clin Pharmacokinet       Date:  1999-06       Impact factor: 6.447

Review 8.  Impact of smoking on asthma therapy: a critical review of clinical evidence.

Authors:  Eric Livingston; Neil C Thomson; George W Chalmers
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 9.  Interindividual variation and drug interactions with hormonal steroid contraceptives.

Authors:  D J Back; A M Breckenridge; F E Crawford; M MacIver; M L Orme; P H Rowe
Journal:  Drugs       Date:  1981-01       Impact factor: 9.546

10.  Plasma propranolol concentrations and the erythrocyte sedimentation rate.

Authors:  R E Schneider; H Bishop; C F Hawkins
Journal:  Br J Clin Pharmacol       Date:  1979-07       Impact factor: 4.335

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.